Conference Reports for NaTaP

EASL - The International Liver Congress 2015 50th annual Meeting of the European association for the Study of the Liver Vienna, austria  april 22-26 Back

Effect of the combination of the HBV core inhibitor NVR 3-778 with Nucleoside Analogs or other HBV core inhibitors on the inhibition of HBV DNA Replication in HepG2.2.15 cells       Reported by Jules Levin EASL 2015 April 22-26 Vienna Austria   A Lam, C Espiritu, L Flores, G Hartman, and K Klumpp Novira Therapeutics Inc., Doylestown, PA, USA   First patient study is ongoing.